<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSES: Most <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> develop from <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath>, which are detected by colonoscopy </plain></SENT>
<SENT sid="1" pm="."><plain>African Americans (AAs) have higher incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and greater mortality from this disease than Caucasian Americans (CAs) </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether differences in predisposition to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and its surrogate (colonic <z:mpath ids='MPATH_270'>adenomas</z:mpath>) between these ethnic groups were related to numbers of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem or stem-like cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) in colonocytes </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We analyzed colonic effluent from 11 AA and 14 CA patients who underwent scheduled colonoscopy examinations at the John D </plain></SENT>
<SENT sid="4" pm="."><plain>Dingell Veterans Affairs Medical Center </plain></SENT>
<SENT sid="5" pm="."><plain>We determined proportions of cells that expressed the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> markers CD44 and CD166 by flow cytometry </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The proportion of colonocytes that were CD44(+)CD166(-) in effluent from patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> was significantly greater than from patients without <z:mpath ids='MPATH_270'>adenomas</z:mpath> (P = 0.01); the proportion of CD44(+)CD166(+) colonocytes was also greater (P = 0.07) </plain></SENT>
<SENT sid="7" pm="."><plain>Effluent from AAs with <z:mpath ids='MPATH_270'>adenomas</z:mpath> had 60 % more CD44(+)166(-) colonocytes than from CAs with <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Using cutoff values of 8 % for AAs and 3 % for CAs, the proportion of CD44(+)166(-) colonocytes that had positive predictive value for detection of <z:mpath ids='MPATH_270'>adenomas</z:mpath> was 100 % for AAs and CAs, determined by receiver operator characteristic curve analysis </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The proportion of CD44(+)166(-) colonocytes in colonic effluent can be used to identify patients with <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>AAs with <z:mpath ids='MPATH_270'>adenomas</z:mpath> have a higher proportion of CD44(+)166(-) colonocytes than CA </plain></SENT>
<SENT sid="11" pm="."><plain>The increased proportion of <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> in colonic tissue from AA might be associated with the increased incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in this population </plain></SENT>
</text></document>